Literature DB >> 11536437

Comparison of antibodies to HBME-1 and calretinin for the detection of mesothelial cells in effusion cytology.

P A Fetsch1, A Simsir, A Abati.   

Abstract

The distinction of mesothelial cells in cytologic samples is often a diagnostic challenge. This is particularly true in potentially malignant effusions in which reactive mesothelial cells may simulate adenocarcinoma (ACA) cells, and in the differentiation of ACA vs. mesothelioma. We sought to determine the superior antibody for the positive identification of mesothelial cells in these circumstances. Cell block sections of 25 reactive and 8 malignant mesothelioma effusions were immunostained with an avidin-biotin procedure, using antibodies to HBME-1 and calretinin. No pretreatment of samples was necessary for the HBME-1-stained slides; microwave antigen retrieval was performed on all slides stained for calretinin. A negative control was performed on each sample. The staining intensity of tumor cells was scored on a scale of 0-3+, with the proportion of immunoreactive cells categorized as <25%, 25-50%, 50-75%, and >75%. The predominant staining pattern for HBME-1 was surface, with rare samples also exhibiting cytoplasmic staining as well. The calretinin-staining pattern was cytoplasmic, with peripheral condensation/prominence and accompanying nuclear staining. All samples were immunoreactive with both antibodies. Fifty-five percent (18/33) of samples showed significantly stronger immunoreactivity with calretinin than with HBME-1; 45% (15/33) of samples showed equivalent staining with the two markers. None of the samples in this study showed stronger immunoreactivity with HBME-1 than with calretinin. Sixty-one percent (20/33) of samples stained with HBME-1 at a moderate (2+) intensity. Fifty-five percent (18/33) of samples stained with calretinin at a strong (3+) intensity. While only 12% of samples showed >75% immunoreactivity for HBME-1, 58% of samples showed >75% of cells immunoreactive for calretinin. Calretinin is the preferred marker in identifying mesothelial cells in cytologic samples, showing the highest sensitivity for mesothelial cells, as evidenced by a more intense staining reaction in a higher percentage of cells than with HBME-1. Published 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536437     DOI: 10.1002/dc.2028

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

Review 1.  Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.

Authors:  Sinchita Roy Chowdhuri; Patricia Fetsch; Jennifer Squires; Elise Kohn; Armando C Filie
Journal:  Diagn Cytopathol       Date:  2012-11-16       Impact factor: 1.582

2.  Hyperbranched polyglycerol is an efficacious and biocompatible novel osmotic agent in a rodent model of peritoneal dialysis.

Authors:  Asher A Mendelson; Qiunong Guan; Irina Chafeeva; Gerald A da Roza; Jayachandran N Kizhakkedathu; Caigan Du
Journal:  Perit Dial Int       Date:  2013 Jan-Feb       Impact factor: 1.756

3.  Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settings.

Authors:  Raman Arora; Shipra Agarwal; Sandeep R Mathur; Kusum Verma; Venkateswaran K Iyer; Manju Aron
Journal:  Cytojournal       Date:  2011-07-28       Impact factor: 2.091

4.  Laparoscopic Peritoneal Wash Cytology-Derived Primary Human Mesothelial Cells for In Vitro Cell Culture and Simulation of Human Peritoneum.

Authors:  Myriam Holl; Lucas Becker; Anna-Lena Keller; Nora Feuerer; Julia Marzi; Daniel A Carvajal Berrio; Peter Jakubowski; Felix Neis; Jan Pauluschke-Fröhlich; Sara Y Brucker; Katja Schenke-Layland; Bernhard Krämer; Martin Weiss
Journal:  Biomedicines       Date:  2021-02-10

Review 5.  Immunocytochemistry of effusion fluids: Introduction to SCIP approach.

Authors:  Vinod B Shidham; Lester J Layfield
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

6.  Retrospective analysis of unknown primary cancers with malignant pleural effusion at initial diagnosis.

Authors:  Takahiro Ebata; Yusuke Okuma; Yoshiro Nakahara; Makiko Yomota; Yusuke Takagi; Yukio Hosomi; Eichi Asami; Yasushi Omuro; Tsunekazu Hishima; Tatsuru Okamura; Yuichi Takiguchi
Journal:  Thorac Cancer       Date:  2015-05-07       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.